Personalized Medicine Market Share 2021: Global Trends, Key Players, Industry Analysis Report to 2027

The Personalized Medicine Market size is expected to grow at an annual average of 10% during 2021-2027. Advances in science and technology, especially the way we explain diseases, develop drugs, and recommend treatments, are changing. The concept of personalized medicine has emerged over the past decade with advances in genomic and protein science, which has led to “targeted” diagnostics that influence knowledge of an individual’s genetic makeup to construct more personalized approaches to health care. and the development of therapeutics. .

The following segmentation are covered in this report:

By Technology

• Big Data Analytics
• Bioinformatics
• Gene Sequencing
• Drug Discovery
• Companion Diagnostics
• Others

By Disease Area

• Oncology
• Respiratory Diseases
• Central Nervous System Disorders
• Immunology
• Genetic Diseases
• Others

Company Profile

• Illumina, Inc.
• GE Healthcare
• Danaher Corporation (Cepheid, Inc.)
• Abbott
• QIAGEN
• Exact Sciences Corporation
• ASURAGEN, INC.
• Biogen
• Dako A/S

Scope of the report

The research study analyses the Personalized Medicine Market industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent developments

• Market overview and growth analysis
• Import and export overview
• Volume analysis
• Current market trends and future outlook
• Market opportunistic and attractive investment segment

Geographic coverage

• North america market size and/or volume
• Latin america market size and/or volume
• Europe market size and/or volume
• Asia-pacific market size and/or volume
• Rest of the world market size and/or volume

Key Questions Answered by Personalized Medicine Market Report

• What was the Personalized Medicine Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027)
• What will be the CAGR of Market during the forecast period (2021-2027)?
• Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
• Which manufacturer/vendor/players in the Personalized Medicine Market was the market leader in 2020?
• Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.